Results 151 to 160 of about 15,000 (182)
Some of the next articles are maybe not open access.
Recombinant human erythropoietin.
Nederlands tijdschrift voor geneeskunde, 1988BECK ANTON K +3 more
openaire +3 more sources
The promise of recombinant human erythropoietin.
Seminars in hematology, 1989Clinical trials have clearly demonstrated the efficacy of recombinant human erythropoietin (r-HuEPO) (EPOGEN [epoetin alfa]; AMGEN Inc, Thousand Oaks, CA) in the treatment of the anemia associated with end-stage renal disease (ESRD). Nearly all dialysis patients treated with r-HuEPO have responded by reaching target hematocrit levels within 8 to 12 ...
openaire +1 more source
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
New England Journal of Medicine, 1987Joseph W Eschbach, J C Egrie, J K Browne
exaly
Recombinant Human Erythropoietin in Children With Cancer
Journal of Pediatric Hematology/Oncology, 1998M L, MacMillan, M H, Freedman
openaire +2 more sources
Human Recombinant Erythropoietin in the Prevention and Treatment of Anemia of Prematurity
Paediatric Drugs, 2012Robin Ohls, Ohls Robin K
exaly
Treatment with Recombinant Human Erythropoietin in Children with Malignancies
Pediatric Hematology and Oncology, 1996E Stiakaki, E Lydaki, M Kalmanti
exaly
Application of Recombinant Human Erythropoietin in Oncology
Cancer Investigation, 1990openaire +2 more sources
Treatment of the Anaemia of Chronic Renal Failure with Recombinant Human Erythropoietin
Drugs, 2012C G Winearls
exaly

